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Abstract
Background: Pyogenic abscess of psoas muscles is a rare condition. Psoas abscess due to methicillin-resistant
Staphylococcus aureus is an emerging and rare infection and so far the related data are scarce.
Case presentation: We report the rare case of primary and bilateral large psoas abscesses due to methicillin-
resistant Staphylococcus aureus in a 54-year-old Arab Jordanian woman with breast cancer who had neutropenia
after starting chemotherapy. She was diagnosed 50 days after onset of symptoms. However, despite this delay in
diagnosis and the large size of the abscesses, she had a full recovery. She was treated with antibiotics and
percutaneous drainage and was doing very well at a follow up of 18 months.
Conclusions: Psoas abscess due to methicillin-resistant Staphylococcus aureus might have insidious presentation
with extensive disease especially in immunocompromised patients. However, it can be managed effectively with
percutaneous catheter drainage and appropriate antibiotic therapy.
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Background
Pyogenic abscess of psoas muscles is a rare condition
with a mortality rate of 100 % if left untreated [1]. The
actual incidence is not known but is believed to have in-
creased in recent years due to improvements in imaging
technology. In one study [2], a significant statistical in-
crease in rates from 0.5 cases per 10,000 hospital admis-
sions from 1993 to 2004 to 6.5 cases per 10,000 hospital
admissions from 2004 to 2007 was reported. Nonethe-
less, the condition is still regarded as a rare disease even
in recent studies [3].
Although Staphylococcus aureus is the leading cause
for primary psoas abscess, psoas abscesses due to
methicillin-resistant Staphylococcus aureus (MRSA) have
been rare until recently when increasing rates have been
reported in the last few years [2, 4, 5]. Therefore, data
on psoas abscess due to MRSA are lacking especially in
regard of treatment [2]. Here, we report a rare case of
primary and bilateral large psoas abscesses due to MRSA
in a neutropenic patient who eventually had an excellent
outcome.
Case presentation
A 54-year-old Arab Jordanian woman who had a history
of breast cancer 11 years prior to her current complaint,
presented in 2012 with a left breast mass due to recur-
rence of her cancer. The mass of the recurrent cancer
was excised and chemotherapy with docetaxel, doxorubi-
cin, and cyclophosphamide was started. However, in
October 2012 and 7 days after the second cycle, she was
admitted because of fever, chills, and right lower quad-
rant pain of 3 days’ duration. Her physical examination
showed epigastric and right lower quadrant tenderness
and her white blood cell count (WBC) was 1.28×109/L
(neutrophils 10 %). Therefore, she was treated with imi-
penem with moderate improvement and was discharged
after 4 days on cefixime orally.
Later, and after the third cycle of chemotherapy which
consisted of docetaxel and cyclophosphamide, she was
admitted again for fever. Her laboratory tests were unre-
markable except for hemoglobin of 7.9 g/dL, WBC
2.6×109/L (neutrophils 15 %), and platelets of 161×109/
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L. During her stay, however, she complained of left hip
and knee pain. Her examination showed tenderness over
her great trochanter with full range of movement.
Therefore, a dedicated left hip magnetic resonance im-
aging (MRI), without pelvic cuts, was performed and
was reported as normal. Her blood and urine cultures
remained negative. She was treated with imipenem and
vancomycin and was later discharged after 8 days of hos-
pital stay.
In December 2012, before receiving the fourth cycle of
chemotherapy, she developed fever, chills, and night
sweats. Her physical examination showed that she was
ill with temperature of 38.7 °C and pulse rate of 90/mi-
nute and her laboratory tests showed WBC of 13.5×109/
L (neutrophils 73 %). An abdomen computed tomog-
raphy (CT) was subsequently performed, 50 days after
onset of symptoms, and showed large bilateral psoas ab-
scesses: the right measuring 13×8×5 cm and the left
9×5×3.5 cm (Fig. 1). Therefore, a bilateral CT-guided
percutaneous drainage (PCD) was inserted. Culture from
the pus grew MRSA which was sensitive to vancomycin,
gentamicin, tigecycline, levofloxacin, erythromycin, clin-
damycin, and chloramphenicol by disk diffusion test. A
lumbosacral MRI with pre- and post-contrast sagittal se-
quences showed no evidence of spondylodiscitis. A
transthoracic echocardiogram was normal. She denied
unsafe sexual practice, recent travel, trauma, alcohol, or
recreational drug use.
After 24 hours of drainage, she became afebrile, was
able to move her hip without pain, and had dramatic im-
provement. She was treated with vancomycin 1 gm ad-
ministered intravenously every 12 hours for 1 week
which was then switched to teicoplanin 400 mg adminis-
tered intramuscularly once daily as an out-patient for
another 3 weeks. One week after drainage, the catheters
were removed and she went home. She received her
fourth cycle of chemotherapy (docetaxel and cyclophos-
phamide) after 4 weeks of drainage without complica-
tions and later on completed another three cycles of
chemotherapy. At follow up of 18 months, she was
doing well and had no evidence of recurrence of infec-
tion on repeat CT imaging.
Discussion
Psoas abscess is classified as either primary or secondary.
A primary abscess occurs due to the hematogenous or
lymphatic spread of the causative organism from a dis-
tant site. Secondary abscess occurs as a result of the dir-
ect expansion of a nearby infectious or inflammatory
process into the psoas muscle [6]. Primary abscess oc-
curs most commonly in patients with a history of dia-
betes, injection drug use, alcoholism, acquired immune
deficiency syndrome, renal failure, hematological malig-
nancies, immunosuppression, or malnutrition [7]. Pri-
mary abscesses account for 99 % of abscesses in Asia
and Africa while in Europe and North America the
prevalence is lower with rates of 18 % and 61 % respect-
ively [1, 6, 7].
Our case has several rare and interesting features: the
primary type, the infection with MRSA, the bilateral lo-
cation, the large size of the abscess, the immunocom-
promised host due to chemotherapy and neutropenia,
and the excellent outcome of the patient.
Bilateral psoas abscesses are rare; Ricci et al. [1] in a
large case series that included every case published in
the literature until 1986 found a rate of 1.4 % of bilateral
abscesses among cases of primary or secondary types.
Navarro López et al. [8] in a comprehensive retrospect-
ive case series which consisted of 124 cases from 11 hos-
pitals in Spain found a rate of 4 % of bilateral abscesses.
Fig. 1 Axial (a) and coronal (b) abdomen and pelvis computed tomography scan with intravenous contrast showing bilateral psoas
muscle abscesses (arrows)
Bakri et al. Journal of Medical Case Reports  (2016) 10:12 Page 2 of 4
Alonso et al. [2], in a case series of 61 patients from
1993 to 2007, found a rate of 16 % of bilateral abscesses.
Here, the bilateral location and the large size of the ab-
scesses are probably due the late diagnosis, the immuno-
compromised host, and the virulence of the infecting
pathogen.
The predominant organism in primary psoas abscess is
S. aureus; Ricci et al. [1], in their large record of case
series up to the year 1986, found that S. aureus caused
88 % of cases followed by Streptococcus (5 %) and
Escherichia coli (3 %). Lai et al. [3] in another record of
case series from 1986 to 2011 also found that S. aureus
was still the dominant etiology. However, despite the fact
that S. aureus was the predominant etiology, MRSA
remained a rare etiology until recently [4, 8]. Two re-
ports have recently documented increasing infection
with MRSA: Alonso et al. [2] and Kim et al. [5]. Alonso
et al. [2] reported the emergence of MRSA as an in-
creasingly common pathogen in a series of 61 cases from
a tertiary care center in the USA. Kim et al. [5] also
showed an increase in infection with MRSA, in Korea,
among 75 cases between two periods: (2001–2006) , and
(2007–2012). Other recent published cases series found
rates of infection with MRSA of two out of 42 cases (4.8
%) [9] and 10 out of 88 (11.4 %) [10].
The phenotype of the isolated MRSA here (sensitive to
levofloxacin, erythromycin, and clindamycin) suggests it
is a community-associated MRSA. However, this pheno-
type criterion remains inaccurate and nucleic acid ampli-
fication methods to detect mecA would have been more
sensitive to differentiate between community and health
care MRSA [11]. Since we did not perform any molecu-
lar tests here, we had to rely on clinical criteria alone to
classify the infection as health care-associated infection
because it presented after admission to our hospital. Of
note, data from our hospital and other hospitals in
Jordan indicate high prevalence of MRSA including
strains with intermediate resistance to vancomycin [12,
13]. We initially opted to treat the patient with vanco-
mycin because it is the drug of choice in such severe in-
fections [11]. Later, we switched her therapy to
teicoplanin because of the easier intramuscular adminis-
tration in the out-patient setting and the similar efficacy
to vancomycin [14].
Currently, whether PCD or surgical intervention
should be used in patients with psoas abscess remains
controversial because few studies with large sample sizes
have been performed [10]. However, at present, PCD is
considered preferable to surgical intervention for the
treatment of psoas abscess [3, 10]. Recently, Hsieh et al.
[10] in a retrospective series of 88 cases, found that ei-
ther PCD or primary surgical intervention is a suitable
treatment for patients with non-gas-forming psoas ab-
scess. Catheter dislocation and obstruction lead to the
majority of complications. However, overall low mortal-
ity and morbidity rates are major advantages of CT-
guided drainage as it is a safe, effective, and less invasive
treatment [15].
Conclusions
MRSA is an increasingly reported and emerging etiology
in psoas abscess. Our case has several rare and interest-
ing features specifically: the primary type, the infection
with MRSA, the bilateral location, the large size of the
abscesses, the immunocompromised host, and the excel-
lent treatment outcome. Psoas abscess is an important
condition in the differential diagnosis of patients with
low back and hip pain. MRI or CT scan could establish
the diagnosis and define the extent of the psoas abscess.
Percutaneous catheter drainage with appropriate anti-
biotic therapy can be effectively used in management.
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